Skip to content
PICO Portalanswers from OpenAlex

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer

PaperCitations, authors & open-access status

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer have?

PICO Portalcitation count

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer has 412 citations in the OpenAlex counts PICO Portal stores.

When was Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer published?

PICO Portalyear

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer has 2014 year in the PICO Portal index.

What is the open-access status of Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer?

PICO Portaloa status

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer has bronze oa status in the PICO Portal index.

What is the DOI of Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer?

PICO Portaldoi

The DOI for Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer is on the source record.

What is the PMID of Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer?

PICO Portalpmid

The PMID for Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer is on the source record.

What is the OpenAlex record for Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer?

PICO Portalopenalex

The OpenAlex for Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial